Click to Return to Home Page
Log In | Register Now

       Help



















 


 


HPLC Application Sheet
Methotrexate: Anti-Neoplastic, Anti-Tumor Drug, Analysis by LCMS

charts

PDF
Click here to view
printable Application Sheet

Note: Cogent TYPE-C™ columns require very little time for equilibration when using a gradient. ANP (Aqueous Normal Phase) is a very MS friendly technique. By using ANP for analysis of polar compounds by LC-MS a 10-100 fold increase of sensitivity is often observed. The sample can be dissolved in water or water + organic solvent mixture, which is advantageous over other analyses.


Method Conditions



Column Cogent Bidentate C18™, 4µm, 100A
Catalog No. 40018-25P
Dimensions 4.6 x 250mm
Mobile Phase A: DI water + 0.5% formic acid
B: Acetonitrile
ANP gradient - gradient conditions
Time (min.) %A %B
0.00 10.0 90.0
1.00 10.0 90.0
5.00 80.0 20.0
10.00 80.0 20.0
10.01 10.0 90.0
12.00 10.0 90.0
Flow rate 0.5 mL/minute
Injection Volume  1 µL
Sample Methotrexate m/z 455
0.1 mg/mL in DI water + 0.5% formic acid
Detection APCI+ Single Ion Monitoring


Discussion


The powerful anticancer drug, methotrexate (4-amino-N10-methylpteroyl glutamic acid) acts as an antimetabolite and is used for the treatment of many neoplastic diseases including acute leukemia, osteosarcoma, non-Hodgkins lymphoma, and breast cancer. There is a great interest in pharmacological studies and clinical monitoring of methotrexate. A quadrupole mass spectrometer operating in the positive – ion mode and an atmospheric pressure ionization (API) source was used for selective detection and assured that no interfering peaks affect the quantitative results. A Cogent bidentate C18 column was the column of choice for the ANP gradient analysis of the drug. The retention of the methotrexate is more than sufficient. The LC-MS method developed assures both high specificity and sensitivity.







[TOP]


Privacy Statement             Copyright © 2005, MicroSolv Technology Corporation.             Site developed by Net Ink Designs.